Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.

ClinicalTrials.gov ID: NCT00315458

Public ClinicalTrials.gov record NCT00315458. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 8:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Determine Efficacy and Safety of Buprenorphine Transdermal System in Subjects With Moderate To Severe Osteoarthritis Pain Requiring Daily Treatment With Opioids

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The original objective of this study was to assess the safety and efficacy of the buprenorphine transdermal system (BTDS) (5, 10, and 20) in comparison to placebo transdermal system in subjects with moderate to severe osteoarthritis pain. However, this study was terminated early with only 35% of the planned sample size, therefore the primary objective is changed to focus on the safety evaluations.

Study identification

NCT ID
NCT00315458
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
107 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2003
Primary completion
Feb 28, 2005
Completion
Feb 28, 2005
Last update posted
Sep 2, 2012

2003 – 2005

United States locations

U.S. sites
48
U.S. states
23
U.S. cities
45
Facility City State ZIP Site status
Parkway Medical Center Birmingham Alabama 35215
Clinical Research Consultants Birmingham Alabama 35244
Winston Physician Services, Inc Haleyville Alabama 35565
Private Practice Muscle Shoals Alabama 35661
Clinic for Rheumatic Diseases Tuscaloosa Alabama 35406
Radiant Research Phoenix Arizona 85013
Arizona Research Center Phoenix Arizona 85023
ACRC/Arizona Clinical Research Tuscon Arizona 85715
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
Southbay Pharma Research Buena Park California 90620
Torrence Clinical Research Torrance California 90505
Comprehensive Neuroscience Inc Boynton Beach Florida 33437
Chiefland Medical Center Chiefland Florida 32626
University Clinical Research Deland DeLand Florida 32720
Florida Medical Research Institute Gainesville Florida 32605
Drug Study Institute Jupiter Florida 33458
Coastal Medical Research Orange City Florida 32763
Ormond Medical Arts Pharmaceutical Res Ctr Ormond Beach Florida 32174
The Arthritis Center Palm Harbor Florida 34684
Avancia Research Pembroke Pines Florida 33024
Coastal Medical Research Port Orange Florida 32127
Palm Beach Research Center West Palm Beach Florida 33409
Gold Coast Research LLC Weston Florida 33321
Georgia Medical Research Institute Marietta Georgia 30060
Internal Medicine Northwest Gurnee Illinois 60031
MediSphere Medical Research Center Evansville Indiana 47714
University of Louisville Medical/Rheumatology Louisville Kentucky 40202
Clinical Trials Management, LLC Metairie Louisiana 70006
Future Care Studies Springfield Massachusetts 01107
Bay Area Health Clinic Bay City Michigan 48706
Medex Healthcare Research Inc St Louis Missouri 63108
Beth Israel Medical Center New York New York 10003
Health Research Institute Oklahoma City Oklahoma 73109
Keystone Clinical Solutions Altoona Pennsylvania 16602
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
BioMedical Research Associates Shippensburg Pennsylvania 17257
University Orthopedics Center State College Pennsylvania 16801
Omega Medical Research Warwick Rhode Island 02886
Low Country Rheumatology Charleston South Carolina 29406
Brown Clinic Watertown South Dakota 57201
Holston Medical Group Bristol Tennessee 37620
CSS Research Memphis Tennessee 38119
Prime Care Medical Center Selmer Tennessee 38375
Team Research of Central Texas Harker Heights Texas 76548
Quality Research San Antonio Texas 78209
Advanced Pain Management and Rehab Hilltop Med Center Virginia Beach Virginia 23454
Sentara Medical Group Virginia Beach Virginia 23462
Physicians Clinic of Spokane Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00315458, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 2, 2012 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00315458 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →